title: Disruption of p21 attenuates lung inflammation induced by cigarette smoke, LPS, and fMLP in mice.
abstract: The cyclin-dependent kinase inhibitor p21(CIP1/WAF1/SDI1) (p21) is an important inhibitory checkpoint regulator of cell cycle progression in response to oxidative and genotoxic stresses. It is known that p21 potentiates inflammatory response and inhibits apoptosis and proliferation, leading to cellular senescence. However, the role of endogenous p21 in regulation of lung inflammatory and injurious responses by cigarette smoke (CS) or other pro-inflammatory stimuli is not known. We hypothesized that p21 is an important modifier of lung inflammation and injury, and genetic ablation of p21 will confer protection against CS and other pro-inflammatory stimuli (lipopolysacchride [LPS] and N-formyl-methionyl-leucyl-phenylalanine [fMLP])-mediated lung inflammation and injury. To test this hypothesis, p21-deficient (p21-/-) and wild-type mice were exposed to CS, LPS, or fMLP, and the lung oxidative stress and inflammatory responses as well as airspace enlargement were assessed. We found that targeted disruption of p21 attenuated CS-, LPS-, or fMLP-mediated lung inflammatory responses in mice. CS-mediated oxidative stress and fMLP-induced airspace enlargement were also decreased in lungs of p21-/- mice compared with wild-type mice. The mechanism underlying this finding was associated with decreased NF-kappaB activation, and reactive oxygen species generation by decreased phosphorylation of p47(phox) and down-modulating the activation of p21-activated kinase. Our data provide insight into the mechanism of pro-inflammatory effect of p21, and the loss of p21 protects against lung oxidative and inflammatory responses, and airspace enlargement in response to multiple pro-inflammatory stimuli. These data may have ramifications in CS-induced senescence in the pathogenesis of chronic obstructive pulmonary disease/emphysema.
authors.affiliation: Lung Biology and Disease Program, Department of Environmental Medicine, University of Rochester Medical Center, 601 Elmwood Ave., Box 850, Rochester, NY 14642, USA.
authors.forename: Hongwei
authors.initials: H
authors.lastname: Yao
authors.forename: Se-Ran
authors.initials: SR
authors.lastname: Yang
authors.forename: Indika
authors.initials: I
authors.lastname: Edirisinghe
authors.forename: Saravanan
authors.initials: S
authors.lastname: Rajendrasozhan
authors.forename: Samuel
authors.initials: S
authors.lastname: Caito
authors.forename: David
authors.initials: D
authors.lastname: Adenuga
authors.forename: Michael A
authors.initials: MA
authors.lastname: O'Reilly
authors.forename: Irfan
authors.initials: I
authors.lastname: Rahman
mesh_terms: D000336:Aerosols; D000818:Animals; D018893:Bronchoalveolar Lavage; D002453:Cell Cycle / Q000502:physiology; D003433:Crosses, Genetic; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000172:deficiency* / Q000235:genetics / Q000502:physiology*; D007249:Inflammation / Q000139:chemically induced / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control*; D008070:Lipopolysaccharides / Q000009:adverse effects / Q000633:toxicity*; D008168:Lung / Q000503:physiopathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000633:toxicity*; D009195:Peroxidase / Q000378:metabolism; D012906:Smoke / Q000009:adverse effects*
chemical_list: D000336:Aerosols; C493957:Cdkn1a protein, mouse; D050759:Cyclin-Dependent Kinase Inhibitor p21; D008070:Lipopolysaccharides; D012906:Smoke; D009240:N-Formylmethionine Leucyl-Phenylalanine; D009195:Peroxidase